Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis

Por Batson, Sarah, Mitchell, Stephen A, Windisch, Ricarda, Damonte, Elisabetta, Munk, Veronica C, Reguart, Noemi
Publicado no Onco Targets Ther (2017)

Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non–Bevacizumab-Containing Therapies in Persistent, R...

Por Rosen, Virginia M., Guerra, Ines, McCormack, Mary, Nogueira-Rodrigues, Angélica, Sasse, Andre, Munk, Veronica C., Shang, Aijing
Publicado no Int J Gynecol Cancer (2017)

Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria

Por Delea, Thomas E., Sofrygin, Oleg, Palmer, James L., Lau, Helen, Munk, Veronica C., Sung, Jennifer, Charney, Alan, Parving, Hans-Henrik, Sullivan, Sean D.
Publicado em 2009